Applied Capital’s AbbVie ABBV Stock Holding History

Applied Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,978	Closed	-$802K	–	34
2022 Q3	$802K	Hold	5,978	–	–	0.55%	28
2022 Q2	$916K	Sell	5,978 -757	-11%	-$116K	0.63%	25
2022 Q1	$1.09M	Hold	6,735	–	–	0.7%	22
2021 Q4	$912K	Hold	6,735	–	–	0.73%	19
2021 Q3	$727K	Hold	6,735	–	–	0.64%	21
2021 Q2	$759K	Hold	6,735	–	–	0.73%	18
2021 Q1	$729K	Buy	+6,735	New	+$720K	0.79%	17

Other funds holding ABBV

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Applied Capital's ABBV Position: Q4 2022 in Review

Applied Capital sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 5,978 shares — an estimated $802K sold.

Applied Capital first reported a position in ABBV in Q1 2021 and held it in 7 quarters. The position peaked at $1.09M in Q1 2022. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Applied Capital reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
Applied Capital sold 5,978 AbbVie shares in Q4 2022, an estimated $802K.
Applied Capital first reported a position in AbbVie in Q1 2021 and held it in 7 quarters.
Applied Capital's AbbVie position peaked at $1.09M in Q1 2022.
3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Applied Capital's 13F filing for Q4 2022, filed 19 Jan 2023.